Japan must bend its strict rules to speed up coronavirus vaccine

It makes little sense to have clinical trials here when lives are at stake

20200410 coronavirus vaccine trial_Data.jpg

A participant in a COVID-19 coronavirus vaccine trial receives an injection in Seattle on Mar. 16: there are human clinical trials underway in the U.S., China and U.K. © AP

Philip Carrigan is the Tokyo-based founder and CEO of Morunda, an executive search business focused on the pharmaceutical and medical device sector.

Scientists all over the world are flouting lockdown laws as they work day and night in hope of finding a coronavirus vaccine. In Japan, companies like AnGes MG and Fujifilm Holdings are working tirelessly to develop COVID-19 treatment options. Despite their diligent efforts, many believe it will be 2021 before treatments or vaccinations are available to the general population.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.